Figures computed from official regulatory filings — .
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Oruka Therapeutics, Inc.Listing on record | Buy | $1M | SEC | |
Oruka Therapeutics, Inc.Listing on record | Buy | $6.3K | SEC | |
Oruka Therapeutics, Inc.Listing on record | Buy | $105K | SEC | |
Oruka Therapeutics, Inc.Listing on record | Buy | $173.9K | SEC | |
Oruka Therapeutics, Inc.Listing on record | Buy | $106.4K | SEC | |
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $382.9K | SEC | |
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $134.3K | SEC | |
KalVista Pharmaceuticals, Inc.Listing unverified | Buy | $104.5K | SEC | |
Synvista Therapeutics, Inc.Listing unverified | Other | — | SEC | |
Synvista Therapeutics, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Synvista Therapeutics, Inc.Listing unverified | Buy | $904.9K | SEC | |
Synvista Therapeutics, Inc.Listing unverified | Buy | $2.2M | SEC | |
Synvista Therapeutics, Inc.Listing unverified | Buy | $1.5M | SEC | |
Synvista Therapeutics, Inc.Listing unverified | Buy | $3.8M | SEC | |
Synvista Therapeutics, Inc.Listing unverified | Buy | $2.7M | SEC | |
Synvista Therapeutics, Inc.Listing unverified | Buy | $216.3K | SEC | |
Bellerophon Therapeutics, Inc.Listing unverified | Buy | $70.8K | SEC | |
Bellerophon Therapeutics, Inc.Listing unverified | Buy | $89.3K | SEC | |
Bellerophon Therapeutics, Inc.Listing unverified | Buy | $92.3K | SEC |